Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth-Reference-Cited by-同舟云学术

Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth

Published:2013-05-01 Issue:6 Volume:123 Page:2475-2487
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Pozo Natividad,Zahonero Cristina,Fernández Paloma,Liñares Jose M.,Ayuso Angel,Hagiwara Masatoshi,Pérez Angel,Ricoy Jose R.,Hernández-Laín Aurelio,Sepúlveda Juan M.,Sánchez-Gómez Pilar

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference63 articles.

1. Louis DN Ohgaki H Wiestler OD Cavenee WK WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon, France: International Agency for Research on Cancer; 2007.

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas

4. Identification of human brain tumour initiating cells

5. Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DYRK1A Interacts with the Tuberous Sclerosis Complex and Promotes mTORC1 Activity;2024-08-20

2. Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer;International Journal of Molecular Sciences;2024-06-21

3. Human Cytomegalovirus Dysregulates Cellular Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases and Sonic Hedgehog Pathway Proteins in Neural Astrocyte and Placental Models;Viruses;2024-06-05

4. Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs;npj Precision Oncology;2024-06-05

5. N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents;Cancers;2024-05-27